What does hemolytic disease of the newborn mean?

Hemolytic disease of the newborn (HDN) is a relatively common clinical condition. Hemolysis may occur either in utero or at birth, leading postnatally to jaundice, anemia, elevated reticulocyte count, and decreased hemoglobin levels. So, what exactly does “hemolytic disease of the newborn” mean? The following section provides a detailed explanation.

What Is Hemolytic Disease of the Newborn?

Hemolytic disease of the newborn refers to an alloimmune hemolytic disorder caused by blood group incompatibility between mother and fetus. In such cases, the mother produces antibodies against fetal red blood cell antigens incompatible with her own blood type; these antibodies cross the placenta and enter the fetal circulation, triggering immune-mediated hemolysis. The most common causes involve incompatibilities in the Rh and ABO blood group systems. Other causes of hemolysis in the neonatal period include inherited defects in red blood cell enzymes or red blood cell membrane structure—each with its own specific diagnostic nomenclature. Only hemolysis resulting from maternal-fetal blood group incompatibility is termed “hemolytic disease of the newborn.” Although HDN is generally treatable, it is essential to rule out two distinct underlying conditions: one genetic and the other due to enzymatic abnormalities. Hemolysis arising from either of these causes can only be managed symptomatically; definitive cure is not possible.

Knowledge Extension: How Is Hemolytic Disease of the Newborn Treated?

1. Prior to delivery, intrauterine transfusion may be performed to ensure adequate red blood cell mass in the fetus.

2. After delivery, treatment options include exchange transfusion and simple red blood cell transfusion; the treatment course may be prolonged.

The above outlines the meaning of hemolytic disease of the newborn. We hope this information is helpful to you.